Liu Xiaoli Jacqueline 4
4 · Evelo Biosciences, Inc. · Filed Jan 29, 2021
Insider Transaction Report
Form 4
Liu Xiaoli Jacqueline
Principal Accounting Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-01-27+24,000→ 24,000 totalExercise: $16.65Exp: 2031-01-27→ Common Stock (24,000 underlying) - Award
Restricted Stock Units
2021-01-27+5,680→ 5,680 totalExercise: $0.00Exp: 2031-01-27→ Common Stock (5,680 underlying)
Footnotes (2)
- [F1]These options will vest in forty-eight (48) substantially equal installments at the end of each monthly anniversary of the date of grant, subject to continued employment on such dates.
- [F2]These restricted stock units will vest in four substantially equal annual installments on the anniversary of the date of grant, subject to continued employment on such dates.